Assessing Sponsor Attitudes Toward Retail Pharmacy Involvement in Clinical Trial Recruitment and Execution
Amid CVS’ surprise exit from the clinical research space and the ensuing broader questions, study investigates the benefits of pharmacy chain involvement—along with the concerns and barriers to adoption.
Introducing PALADIN
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Examining the Impact of Exclusionary Behaviors on Team Dynamics
Tufts CSDD study finds that acts of microaggression negatively impact psychological safety and performance.
Methods to Recruit Healthcare Providers for Virtual Advisory Boards in Drug Development
Tufts CSDD study addresses barriers in recruitment.
Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce
2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
The Impact of Gender Microaggressions on Team Performance in Drug Development
26 interviews conducted by Tufts CSDD found that gender-based microaggressions can negatively impact collaboration and affect retention of women employees.
Assessing Sponsor and CRO Awareness
Improving receptivity and response to the evolving nature of clinical trial patient oversight.